Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialMichel Azizi, J.M. Bartoli, Pierre Lantelme et al.|Circulation|2016Cited by 154
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal DenervationPhilippe Gosse, Michel Azizi, Antoine Crémer et al.|Hypertension|2017Cited by 43
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) TrialPierre‐Yves Courand, Antoine Crémer, Héléna Pereira et al.|Journal of the American Heart Association|2017Cited by 32
Revisiting malignant hypertension: rationale and design of the ‘HAMA cohort’, on behalf of the ESH working group ‘hypertension and the kidney’Romain Boulestreau, Philippe Gosse, Aurélien Lorthioir et al.|Journal of Hypertension|2023Cited by 6
Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohortRomain Boulestreau, Aurélien Lorthioir, Hervé Dréau et al.|Journal of Hypertension|2024Cited by 4